World News | Russia's Permanent Mission, Health Ministry to Present Sputnik V Vaccine at UN on Wednesday
Get latest articles and stories on World at LatestLY. Russia's permanent mission to the UN and the Health Ministry will hold a presentation, which will provide detailed information on the Russian vaccine against the novel coronavirus disease (COVID-19), mission spokesman Fyodor Strzhizhovsky told Sputnik.
Moscow [Russia], December 2 (ANI/Sputnik): Russia's permanent mission to the UN and the Health Ministry will hold a presentation, which will provide detailed information on the Russian vaccine against the novel coronavirus disease (COVID-19), mission spokesman Fyodor Strzhizhovsky told Sputnik.
During a speech at the UN General Assembly in September, Russian President Vladimir Putin suggested that the organisation's employees be provided with the Russian vaccine against coronavirus free of charge. Russia's Permanent Representative to the UN Vassily Nebenzia, in turn, did not rule out that the vaccine developers would present it at the UN headquarters.
Also Read | COVID-19 Vaccine to be Administered For Free in Japan, Yoshihide Suga Govt Passes Bill in Parliament.
"On Wednesday, December 2, a presentation of the Russian Sputnik V vaccine will take place. Russian Health Minister Mikhail Murashko, Russia's Permanent Representative to the UN Vassily Nebenzia, and head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriyev will take part in the event," Strzhizhovsky said.
He said a virtual event entitled "Sputnik V: Vaccine Against COVID-19" will be held on the sidelines of a special session of the UN General Assembly. During the meeting, detailed information on the Russian vaccine will be presented.
Also Read | COVID-19 Vaccination Update: First Coronavirus Vaccines Will Go to Healthcare Workers, Says US Panel.
In August, Russia's Health Ministry registered the world's first vaccine for the prevention of COVID-19, developed by the Gamaleya Research Centre. It was named Sputnik V. The vaccine is based on a well-studied and validated human adenoviral vector platform, the important benefits of which are safety, efficacy and no long-term adverse effects. (ANI/Sputnik)
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)